Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]

Mouse models and proteomics tackling acute lymphoblastic leukaemia

Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland

Mouse models and proteomics tackling acute lymphoblastic leukaemia ( Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland )

New drugs for relapsed and refractory Hodgkin's lymphoma

Prof Anas Younes - MD Anderson Cancer Center, Houston, USA

$New drugs for relapsed and refractory Hodgkin's lymphoma ( Prof Anas Younes - MD Anderson Cancer Center, Houston, USA )$

Phase 1-2 results for oral proteasome inhibitor MLN9708 for multiple myeloma...

Dr Rafael Fonseca – Mayo Clinic, Arizona, USA

Phase 1-2 results for oral proteasome inhibitor MLN9708 for multiple myeloma (Spanish) ( Dr Rafael Fonseca – Mayo Clinic, Arizona, USA )

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy

Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy ( Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA )

MEK inhibitor, trametinib, improves progression free survival in melanoma

Dr Caroline Robert – Institute Gustave Roussy, Paris, France

MEK inhibitor, trametinib, improves progression free survival in melanoma ( Dr Caroline Robert – Institute Gustave Roussy, Paris, France )

SUCCEED trial: Maintenance treatment in advance soft tissue sarcoma

Dr Jean Yves-Blay - University Claude Bernard, Lyon, France

SUCCEED trial: Maintenance treatment in advance soft tissue sarcoma ( Dr Jean Yves-Blay - University Claude Bernard, Lyon, France )

Drug development in small cell and non-small cell lung cancer

Dr Leora Horn - Vanderbilt-Ingram Cancer Center, Nashville, USA

Drug development in small cell and non-small cell lung cancer ( Dr Leora Horn - Vanderbilt-Ingram Cancer Center, Nashville, USA )

ASCO 2012 Drug Development Research Professorship

Dr Alex Adjei - Roswell Park Cancer Institute, Las Vegas, USA

ASCO 2012 Drug Development Research Professorship ( Dr Alex Adjei - Roswell Park Cancer Institute, Las Vegas, USA )

Early phase trial of ibrutinib for chronic lymphocytic leukaemia

Dr Samantha Jaglowski - Ohio State University Medical Center, Columbus, USA

Early phase trial of ibrutinib for chronic lymphocytic leukaemia ( Dr Samantha Jaglowski - Ohio State University Medical Center, Columbus, USA )

Novel PET tracers and their future use in assessment of response to treatment

Dr Andrei Iagaru – Stanford University, CA, USA

Novel PET tracers and their future use in assessment of response to treatment ( Dr Andrei Iagaru – Stanford University, CA, USA )

Acute Lymphocytic Leukemia: impressive results with a bispecific antibody in...

Prof Max Topp - University of Wuerzberg, Germany

$Acute Lymphocytic Leukemia: impressive results with a bispecific antibody in patients with refractory disease ( Prof Max Topp - University of Wuerzberg, Germany )$

Treating metastatic melanoma with vemurafenib

Dr Paul Chapman – Memorial Sloan-Kettering Cancer Center, New York, USA

Treating metastatic melanoma with vemurafenib ( Dr Paul Chapman – Memorial Sloan-Kettering Cancer Center, New York, USA )

More from ecancer